The Sexual Revolution in Science: What Gender-Based Research is Telling Us

Haseltine FP. Gender based biology-the next step. Jour Women's Health 1995;4:221–2.

Makkar RR , Fromm BS , Steinman RT , Meissner MD , Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. J Am Med Assn 1993;270(21):2590–7.

Pregler J. Organization Statement. Los Angeles (CA): UCLA National Center of Excellence in Women's Health; 1998.

Lovejoy JC , Ryan DH. Organizational Statement. Baton Rouge (LA): Pennington Biomedical Research Center, Louisiana State University; 1998.

Leibowitz SF , Akabayashi A , Alexander JT , Wang J. Gonadal steroids and hypothalamic galatin and neuropeptide Y: role in eating behavior and body weight control in female rats. Endocrinology 1998;139(4):1771–80.

Casabiell X , Pineiro V , Peino R , Lage M , Camina J , Gallego R , . J Clin Endocrinol Metab 1998;83(6):2149–55.

Donovan JM , Wolf JL , Drossman D , Kaplan LM. Organizational Testimony. Boston (MA): Gastroenterology Women's Coaliton; 1998.

Northcull AR , Carnilleria M , Mayer EA , Drossman DA , Dukes GE , Ehsanullah RSB , Hamm LR , Harding JP , Heath AT , Jacques L , . Alosetron, a 5HT,-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients. Gastroenterology 1998;114:A812.

Tosi LL , Schwaab RR. Organizational Testimony. Rosemont (IL): American Academy of Orthopaedic Surgeons, 1998.

McLaughlin M. Rethinking Estrogen Function. Pittsburgh (PA): Magee-Women's Research Institute and Hospital, The University of Pittsburgh College of Medicine, 1998.

Wise SS. Advances in Women's Health Research. Bethesda (MD): National Institute of Dental Research, 1998.

Wisner KL. Organizational Testimony. Cleveland (OH): Case Western Reserve University; 1998.

Freund KM. Research Statement for 1997-1998. Boston (MA): Boston University Center of Excellence in Women's Health, 1998.

Rico MJ. Organizational Testimony. New York (NY): Committee for the Advancement of the Dermatologic Health of Women, 1998.

Zang EA , Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Nat Cancer Inst 1996;21;88(3-4):183–92.

Levy AT. Organizational Testimony. Bethesda (MD): National Cancer Institute, 1998.

Fuchs CS , Giovannucci EL , Colditz GA , Hunter DJ , Stampfer MJ , Rosner B , Speizer FE. Willott WC. Dietary fiber and the risk of colorectal cancer and adenoma in women. New Engl J Med 1999;21;340(3):169–76.

Horn EP , Tucker MA , Lambert G , Silverman D , Zametkin D , Sinha R , . A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer. Cancer Epidemiol Biomarkers Prev 1995;4(5):529–33.

Kerr LA. American Urological Association Testimony. Colchester (VT): American Urological Association, 1998.

Winston M. Organizational Testimony. Dallas (TX): American Heart Association, 1998.

Merz CNB. Organization Statement. Los Angeles (CA): Women's Ischemia Syndrome Evaluation (WISE) Study; 1998.

Gear RW , Gordon NC , Heller PH , Paul S , Miaskowski C , Levine JD. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 1996;1;205(3):207–9.

Wetherington CL. Recent advances in gender-based drug abuse research. Bethesda (MD): National Institute on Drug Abuse, 1998.

Lukas SE , Sholar M , Lundahl LH , Lamas X , Kouri E , Wines JD , Kragie L , Mendelson JD. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 1996;125(4):346–54.

Levin JM , Holman BL , Mendelson JH , Teoh SK , Garada B , Johnson KA , Springer S. Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. J Nucl Med 1994;35:1902–9.

Chang L , Ernst T , Strickland TL. Neurochemical abnormalities and gender effects in abstinent asympotmatic cocaine users [abstract]. The Society of Magnetic Resonance Fourth Scientific Meeting, New York, NY, 1996.

Messina ES , Tyndale RF , Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997;282:277–85.

Health AC , Madden PAF , Martin NG. Statistical methods in genetic research on smoking. Stat Methods Med Res 1998;7:165–86.

Morrell MJ. Organizational Statement. New York: Epilepsy Foundation, 1998.

Gur RE. Gender differences in brain and behavior. Philadelphia: University of Pennsylvania, 1998.

Parron DL. Organizational Testimony. Bethesda: National Institutes of Mental Health, 1998.

Nishizawa S , Benkelfat SN , Young M , Leyton M , Mzengeza C , de Montigny P , Blier P , Diksic M. Differences between males and females in rates of serotonin synthesis in the human brain. Proc Natl Acad Sci USA 1997;13;94(10):5308–13.

Shively C. Gender-based biology at Wake Forest University Baptist Medical Center. Winston-Salem: Wake Forest University Baptist Medical Center, 1998.

Stewart DE. Organization Statement. Toronto: American Psychiatric Association, 1998.

Miers ML. Organizational Testimony. Bethesda: National Institute of Neurological Disorders and Stroke, 1998.

Farzadegan H , Hoover DR , Astemborski J , Lyles CM , Margolick JB , Markham RB , Quinn TC , Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510–4.

Marengo SR , Resnick MI , Yang L , Chung JY. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men. J Urol 1998;159(5):1444–50.

Morita T , Masuda H , Tosaka A , Ishizaka K , Tsujii T , Kondo S. Sex differences in function and distribution of beta-adrenoceptors in rabbit urinary bladder. J Urol 1998;159(2):555–8.

Laqueur T. Making sex: body and gender from the Greeks to Freud, 1990.

Johnson TL , Fee E. Women's health research: an historical perspective. In: Haseltine FP , Jacobson BG. Women's health research: a medical and policy primer, 1st ed. Washington, DC: Health Press International, 1997;27–43.